Sun Pharma may slip to Rs 485: Sukhani

Sun Pharma may slip to Rs 485, says Sudarshan Sukhani, s2analytics.com.

Sukhani told CNBC-TV18, "After a very sharp run up pharma stocks have begun a deep correction. Now we are selling to take advantage of that correction, the profits are likely to be limited. We need to be nimble because the primary trend for pharma is up but within that professional traders can take advantage of these downside moves in any stock not just Sun Pharma. Sun Pharma gives a target of Rs 485 and it could be lower."
He further added, "Same story with Cipla although Sun Pharma